KYNTRA BIO, INC. (KYNB): Submission of Matters to a Vote of Security Holders
KYNTRA BIO, INC. (KYNB) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. 8-K 0000921299 false 0000921299 2026-06-12 2026-06-12 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 12,
How this was made
The 30-second read
Why it matters
The disclosed items are standard: election of a Class III director, advisory approval of executive compensation, and ratification of the independent auditor for 2026.
Market read
Provides governance/auditor confirmation but no new financial or strategic information.
What to watch
Traders may watch for follow-on filings (e.g., subsequent 10-K/8-K items) rather than the vote counts themselves.
Background
The article is an SEC Form 8-K (Item 5.07) summarizing results from Kyntra Bio’s June 12, 2026 annual stockholder meeting.
Ticker impact
Kyntra Bio’s 8-K reports June 12, 2026 shareholder votes, including election of Michael Kauffman and ratification of PwC as auditor.
Limited near-term impact; any reaction likely confined to governance/overhang sentiment rather than fundamentals.
The filing discloses voting results (director election, advisory say-on-pay, auditor ratification) without new guidance, transactions, or regulatory/clinical updates.
Market effects
Minimal; governance/auditor ratification is not sector-moving.
None indicated; US-listed microcap governance filing.
None indicated.
Counterpoint
If there were contested governance issues, vote tallies could hint at shareholder dissatisfaction; however, the filing provides no context beyond results.
Key entities
- issuerKyntra Bio, Inc.
Nasdaq-listed company filing the 8-K with shareholder vote results.
- director_nomineeMichael Kauffman, M.D., Ph.D.
Class III director nominee elected to serve until the 2029 annual meeting.
- auditorPricewaterhouseCoopers LLP
Ratified as independent registered public accounting firm for year ending Dec. 31, 2026.
